Sintx Technologies (SINT) Other Non Operating Income (2013 - 2026)
Sintx Technologies' (SINT) quarterly Other Non Operating Income came in at $33000.0 in Q1 2026, up 3200.0% year-on-year from $1000.0 in Q1 2025, and down 80.81% quarter-over-quarter from $172000.0 in Q4 2025.
Sintx Technologies (SINT) Other Non Operating Income (2013 - 2026) Analysis & Trends
Sintx Technologies' Other Non Operating Income history runs 14 years deep, the most recent figure standing at $33000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 3200.0% year-over-year to $33000.0 in Q1 2026; TTM through Mar 2026 was -$48000.0, a 98.31% increase from a year earlier, with the FY2025 full-year figure at $6000.0, up 200.0% from the prior year.
- Other Non Operating Income fell to $33000.0 in Q1 2026 per SINT's latest filing, from $172000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $786000.0 in Q1 2023 and bottomed at -$5.3 million in Q4 2023.
- The 5-year median for Other Non Operating Income is $33000.0 (2026), against an average of -$391882.4.
- Across the five-year window, Other Non Operating Income plunged 3161.49% in 2023 and soared 15033.33% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at $174000.0 in 2022, then plunged by 3161.49% to -$5.3 million in 2023, then soared by 35.1% to -$3.5 million in 2024, then jumped by 104.98% to $172000.0 in 2025, then tumbled by 80.81% to $33000.0 in 2026.
- Per Business Quant, the three latest SINT Other Non Operating Income figures stand at $33000.0 (Q1 2026), $172000.0 (Q4 2025), and -$214000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33,000.00 |
| Dec 31, 2025 | 172,000.00 |
| Sep 30, 2025 | -214,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | -3.46 Mn |
| Sep 30, 2024 | 173,000.00 |
| Jun 30, 2024 | 448,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | -5.33 Mn |
| Sep 30, 2023 | 374,000.00 |
| Jun 30, 2023 | -3,000.00 |
| Mar 31, 2023 | 786,000.00 |
| Dec 31, 2022 | 174,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 162,000.00 |
| Mar 31, 2022 | 41,000.00 |
| Dec 31, 2021 | 471,000.00 |
| Sep 30, 2021 | 481,000.00 |
| Jun 30, 2021 | -14,000.00 |